Iron deficiency markers in patients with advanced heart failure
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F24%3A00081766" target="_blank" >RIV/00159816:_____/24:00081766 - isvavai.cz</a>
Result on the web
<a href="https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.3326" target="_blank" >https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.3326</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Iron deficiency markers in patients with advanced heart failure
Original language description
Introduction: Iron deficiency (ID) is a common comorbidity in patients with advanced heart failure (HF). It is associated with decreased performance status, frequent hospitalizations for HF decompensation, and lower quality of life. There is an ongoing debate about the optimal definition of ID and the selection of patients benefiting from iron supplementation. Previously, ID in HF was defined as ferritin < 100 μg/l, or 100-299 μg/l if transferrin saturation (T-sat) was < 20%. In light of new findings, the definition of ID has been simplified in the Update ESC Guidelines for the Diagnosis and Treatment of HF to T-sat < 20% or ferritin < 100 μg/l.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30200 - Clinical medicine
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů